Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
Condition(s):Branch Retinal Vein OcclusionLast Updated:January 30, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Branch Retinal Vein OcclusionLast Updated:January 30, 2023Terminated
Condition(s):Diabetic Macular Edema; Macular Edema; Retinal Vein OcclusionLast Updated:December 3, 2018Unknown status
Condition(s):Macular Edema; Diabetic RetinopathyLast Updated:November 26, 2018Unknown status
Condition(s):Macular EdemaLast Updated:February 28, 2022Completed
Condition(s):Branch Retinal Vein Occlusion With Macular EdemaLast Updated:December 3, 2020Unknown status
Condition(s):Diabetic Retinopathy; Diabetic Macular EdemaLast Updated:November 2, 2023Active, not recruiting
Condition(s):Diabetes Mellitus; Diabetic Retinopathy; Diabetic Macular EdemaLast Updated:January 22, 2020Completed
Condition(s):Diabetic Macular Edema of Both Eyes (Diagnosis); Diabetic Retinopathy Visually ThreateningLast Updated:September 11, 2018Unknown status
Condition(s):Diabetic Retinopathy; Macular EdemaLast Updated:December 2, 2021Completed
Condition(s):Diabetic Retinopathy; Macular EdemaLast Updated:December 2, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.